First, it is possible that the LBs identified in these patents represent incidental LB disease (iLBD), which is described on postmortem examination in controls of increasing age,17–19 ie, the LBs represent presymptomatic PD, but the parkin or PINK1 mutations have produced the clinical syndrome. Here, PRKN is linked to Parkinson disease.